PRIME Cohort Studies

2019-01-29T14:15:57Z (GMT) by Maggie Marx Gillian Hanslo Crick Lund
<p>The cohort studies are treatment cohorts which assessed the clinical, social and economic outcomes of patients who have received a diagnosis of depression, alcohol use disorder (AUD), psychosis or epilepsy. In some countries a control group (patients who screen positive for a disorder but were undiagnosed by a clinician) were also followed up. <br></p><p><br></p><p>Key research themes included social, health and economic outcomes, equity of access, and stigma, discrimination, adherence and retention in care. After the baseline data collection, patients were followed-up after 3 or 6 months (midline visit), and again 12 months after the baseline (endline visit). A detailed description of the cohort methods has been published in BMC Psychiatry (https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-018-1642-x<a>).</a> <br></p><p><br></p><p>Below is a brief overview of the design, recruitment and data collection methods. <br></p><p><br></p> <p> </p> If you wish to access the cohort dataset, please complete an expression of interest form at https://docs.google.com/forms/d/e/1FAIpQLSfp9sVy_OKV18AWJfUlBGVnC_QuLyCalR4xVJR4tAMRR5g1wg/viewform <div><hr></div>